triiodothyronine has been researched along with captopril in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, LY; Liu, YH; Song, T; Wu, SJ; You, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bahl, JJ; Goldman, S; Morkin, E; Pennock, GD; Raya, TE | 1 |
| Correa-Rotter, R; Ibarra-Rubio, ME; Medina-Campos, ON; Pedraza-ChaverrÃ, J | 1 |
| Ismail-Beigi, F; Queiroz, MS; Shao, Y | 1 |
1 review(s) available for triiodothyronine and captopril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for triiodothyronine and captopril
| Article | Year |
|---|---|
Impairment of endothelium-dependent relaxation of rat aortas by homocysteine thiolactone and attenuation by captopril.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Captopril; Dose-Response Relationship, Drug; Enalaprilat; Endothelium, Vascular; Free Radicals; Homocysteine; Losartan; Malondialdehyde; Nitric Oxide; Nitroprusside; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Vasodilation | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Studies on the use of thyroid hormone and a thyroid hormone analogue in the treatment of congestive heart failure.
Topics: Animals; Captopril; Cardiac Output; Cattle; Diiodothyronines; Heart Failure; Hemodynamics; Humans; Propionates; Rats; Receptors, Thyroid Hormone; Triiodothyronine | 1993 |
Regulation of hepatic angiotensinogen gene expression in nephrotic rats.
Topics: Adrenalectomy; Angiotensinogen; Animals; Captopril; Dexamethasone; Ethinyl Estradiol; Gene Expression Regulation; Liver; Male; Nephrectomy; Nephrotic Syndrome; Rats; Rats, Wistar; Renin; RNA, Messenger; Triiodothyronine | 1997 |
Effect of thyroid hormone on uncoupling protein-3 mRNA expression in rat heart and skeletal muscle.
Topics: Adrenergic beta-Agonists; Animals; Antihypertensive Agents; Body Weight; Captopril; Carrier Proteins; Clenbuterol; Drug Synergism; Hyperthyroidism; Ion Channels; Male; Mitochondrial Proteins; Muscle, Skeletal; Myocardium; Organ Size; Propranolol; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triiodothyronine; Uncoupling Protein 3 | 2004 |